Correlation
The correlation between STRO and RNA is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
STRO vs. RNA
Compare and contrast key facts about Sutro Biopharma, Inc. (STRO) and Avidity Biosciences, Inc. (RNA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: STRO or RNA.
Performance
STRO vs. RNA - Performance Comparison
Loading data...
Key characteristics
STRO:
-0.66
RNA:
0.20
STRO:
-1.05
RNA:
0.91
STRO:
0.87
RNA:
1.11
STRO:
-0.80
RNA:
0.33
STRO:
-1.46
RNA:
0.59
STRO:
53.69%
RNA:
29.76%
STRO:
120.00%
RNA:
72.87%
STRO:
-98.10%
RNA:
-86.45%
STRO:
-96.74%
RNA:
-40.99%
Fundamentals
STRO:
$76.02M
RNA:
$3.73B
STRO:
-$2.91
RNA:
-$3.00
STRO:
1.14
RNA:
418.25
STRO:
2.11
RNA:
2.81
STRO:
$66.43M
RNA:
$8.93M
STRO:
$2.55M
RNA:
$5.93M
STRO:
-$200.97M
RNA:
-$431.82M
Returns By Period
In the year-to-date period, STRO achieves a -51.21% return, which is significantly lower than RNA's 6.53% return.
STRO
-51.21%
-16.10%
-66.12%
-78.75%
-40.91%
-38.26%
N/A
RNA
6.53%
-5.23%
-28.00%
15.34%
30.53%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
STRO vs. RNA — Risk-Adjusted Performance Rank
STRO
RNA
STRO vs. RNA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sutro Biopharma, Inc. (STRO) and Avidity Biosciences, Inc. (RNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
STRO vs. RNA - Dividend Comparison
Neither STRO nor RNA has paid dividends to shareholders.
Drawdowns
STRO vs. RNA - Drawdown Comparison
The maximum STRO drawdown since its inception was -98.10%, which is greater than RNA's maximum drawdown of -86.45%. Use the drawdown chart below to compare losses from any high point for STRO and RNA.
Loading data...
Volatility
STRO vs. RNA - Volatility Comparison
Sutro Biopharma, Inc. (STRO) has a higher volatility of 30.54% compared to Avidity Biosciences, Inc. (RNA) at 26.12%. This indicates that STRO's price experiences larger fluctuations and is considered to be riskier than RNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
STRO vs. RNA - Financials Comparison
This section allows you to compare key financial metrics between Sutro Biopharma, Inc. and Avidity Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities